Journal
ADVANCED MATERIALS
Volume -, Issue -, Pages -Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.202310605
Keywords
activatable molecular probes; chemiluminescence imaging; drug toxicity; neuron imaging
Ask authors/readers for more resources
Chemotherapy-induced peripheral neuropathy (CIPN) is common in cancer patients but poorly managed due to the lack of reliable diagnostic techniques. In this study, a near-infrared chemiluminophore (MPBD) was synthesized and developed into a water-soluble activatable probe (CalCL) for in vivo imaging of CIPN. The probe allows for sensitive detection of paclitaxel-mediated CIPN in living mice, which is not achievable with fluorescence imaging. This research not only develops a highly efficient chemiluminescent probe, but also presents the first optical imaging approach for high-throughput screening of neurotoxic drugs.
Chemotherapy-induced peripheral neuropathy (CIPN) has a high prevalence but is poorly managed for cancer patients due to the lack of reliable and sensitive diagnostic techniques. Molecular optical imaging can provide a noninvasive way for real-time monitoring of CIPN; However, this is not reported, likely due to the absence of optical probes capable of imaging deep into the spinal canal and possessing sufficient sensitivity for minimal dosage through local injection into the dorsal root ganglia. Herein, a near-infrared (NIR) chemiluminophore (MPBD) with a chemiluminescence quantum yield higher than other reported probes is synthesized and a NIR activatable chemiluminescent probe (CalCL) is developed for in vivo imaging of CIPN. CalCL is constructed by caging MPBD with calpain-cleavable peptide moiety while conjugating polyethylene glycol chain to endow water solubility. Due to the deep-tissue penetration of chemiluminescence and specific turn-on response of CalCL toward calpain (a hallmark of CIPN), it allows for sensitive detection of paclitaxel-mediated CIPN in living mice, which is unattainable by fluorescence imaging. This study thus not only develops a highly efficient chemiluminescent probe, but also presents the first optical imaging approach toward high-throughput screening of neurotoxic drugs. A highly bright near-infrared chemiluminophore is synthesized and developed into a water-soluble activatable probe (CalCL) for in vivo imaging of drug-induced peripheral neuropathy.image
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available